Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery

NCT00906295 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT00906295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00906295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2009
Completion date
June 30, 2011
Enrollment
67 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, arthroplasty, hip, replacement